Official recall notice

FDA DrugClass IINotable

FDA Recall: Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 100 Tablets (10 x 10 unit dose blisters) per

Recall date
2026-07-29
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Subpotent Drug

Product description

Subpotent Drug

Affected products

Lot #: N02266, Exp. Date 11/2026

Verify with the official notice →
Share:

Related Recalls

2026-07-29 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 unit dose blisters) per c
Major Pharmaceuticals
2026-07-29 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 100 Tablets (10 x 10 unit dose blisters) per c
Major Pharmaceuticals
2026-07-29 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 100 Tablets (10 x 10 unit dose blisters) per c
Major Pharmaceuticals
2026-07-29 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 10 Tablets (10 x 1) unit dose blisters per c
Major Pharmaceuticals